These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9497260)

  • 1. Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient glycoprotein syndrome type 1A.
    Matthijs G; Schollen E; Van Schaftingen E; Cassiman JJ; Jaeken J
    Am J Hum Genet; 1998 Mar; 62(3):542-50. PubMed ID: 9497260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome).
    Matthijs G; Schollen E; Pardon E; Veiga-Da-Cunha M; Jaeken J; Cassiman JJ; Van Schaftingen E
    Nat Genet; 1997 May; 16(1):88-92. PubMed ID: 9140401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of homozygosity for predominant mutations in PMM2 in Danish patients with carbohydrate-deficient glycoprotein syndrome type 1.
    Kjaergaard S; Skovby F; Schwartz M
    Eur J Hum Genet; 1998; 6(4):331-6. PubMed ID: 9781039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mutations found in carbohydrate-deficient glycoprotein syndrome type IA on the activity of phosphomannomutase 2.
    Pirard M; Matthijs G; Heykants L; Schollen E; Grünewald S; Jaeken J; van Schaftingen E
    FEBS Lett; 1999 Jun; 452(3):319-22. PubMed ID: 10386614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missense mutations in phosphomannomutase 2 gene in two Japanese families with carbohydrate-deficient glycoprotein syndrome type 1.
    Kondo I; Mizugishi K; Yoneda Y; Hashimoto T; Kuwajima K; Yuasa I; Shigemoto K; Kuroda Y
    Clin Genet; 1999 Jan; 55(1):50-4. PubMed ID: 10066032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Missense mutations in the phosphomannomutase 2 gene of two Japanese siblings with carbohydrate-deficient glycoprotein syndrome type I.
    Mizugishi K; Yamanaka K; Kuwajima K; Yuasa I; Shigemoto K; Kondo I
    Brain Dev; 1999 Jun; 21(4):223-8. PubMed ID: 10392743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal diagnosis and the subsequent mutation analysis in a family with carbohydrate-deficient glycoprotein type I syndrome: growing evidence to support founder effects within CDG1 populations.
    Crosby A; Jeffery S; Homfray T; Taylor R; Patton M
    Genet Test; 1999; 3(3):305-7. PubMed ID: 10495932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A frequent mild mutation in ALG6 may exacerbate the clinical severity of patients with congenital disorder of glycosylation Ia (CDG-Ia) caused by phosphomannomutase deficiency.
    Westphal V; Kjaergaard S; Schollen E; Martens K; Grunewald S; Schwartz M; Matthijs G; Freeze HH
    Hum Mol Genet; 2002 Mar; 11(5):599-604. PubMed ID: 11875054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yeast Models of Phosphomannomutase 2 Deficiency, a Congenital Disorder of Glycosylation.
    Lao JP; DiPrimio N; Prangley M; Sam FS; Mast JD; Perlstein EO
    G3 (Bethesda); 2019 Feb; 9(2):413-423. PubMed ID: 30530630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scandinavian CDG-Ia patients: genotype/phenotype correlation and geographic origin of founder mutations.
    Erlandson A; Bjursell C; Stibler H; Kristiansson B; Wahlström J; Martinsson T
    Hum Genet; 2001 May; 108(5):359-67. PubMed ID: 11409861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbohydrate-deficient glycoprotein syndrome type 1A: expression and characterisation of wild type and mutant PMM2 in E. coli.
    Kjaergaard S; Skovby F; Schwartz M
    Eur J Hum Genet; 1999 Dec; 7(8):884-8. PubMed ID: 10602363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Denaturing high-performance liquid chromatography is a suitable method for PMM2 mutation screening in carbohydrate-deficient glycoprotein syndrome type IA patients.
    Erlandson A; Stibler H; Kristiansson B; Wahlström J; Martinsson T
    Genet Test; 2000; 4(3):293-7. PubMed ID: 11142762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional significance of PMM2 mutations in mildly affected patients with congenital disorders of glycosylation Ia.
    Westphal V; Peterson S; Patterson M; Tournay A; Blumenthal A; Treacy EP; Freeze HH
    Genet Med; 2001; 3(6):393-8. PubMed ID: 11715002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterodimerization of Two Pathological Mutants Enhances the Activity of Human Phosphomannomutase2.
    Andreotti G; Monti MC; Citro V; Cubellis MV
    PLoS One; 2015; 10(10):e0139882. PubMed ID: 26488408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of the phosphomannomutase genes PMM1, PMM2 and PMM2psi: the sequence variation in the processed pseudogene is a reflection of the mutations found in the functional gene.
    Schollen E; Pardon E; Heykants L; Renard J; Doggett NA; Callen DF; Cassiman JJ; Matthijs G
    Hum Mol Genet; 1998 Feb; 7(2):157-64. PubMed ID: 9425221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia).
    Schollen E; Kjaergaard S; Legius E; Schwartz M; Matthijs G
    Eur J Hum Genet; 2000 May; 8(5):367-71. PubMed ID: 10854097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital disorder of glycosylation type Ia: searching for the origin of common mutations in PMM2.
    Quelhas D; Quental R; Vilarinho L; Amorim A; Azevedo L
    Ann Hum Genet; 2007 May; 71(Pt 3):348-53. PubMed ID: 17166182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the 415G>A (E139K) PMM2 mutation in carbohydrate-deficient glycoprotein syndrome type Ia disrupting a splicing enhancer resulting in exon 5 skipping.
    Vuillaumier-Barrot S; Barnier A; Cuer M; Durand G; Grandchamp B; Seta N
    Hum Mutat; 1999 Dec; 14(6):543-4. PubMed ID: 10571956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression analysis revealing destabilizing mutations in phosphomannomutase 2 deficiency (PMM2-CDG): expression analysis of PMM2-CDG mutations.
    Vega AI; Pérez-Cerdá C; Abia D; Gámez A; Briones P; Artuch R; Desviat LR; Ugarte M; Pérez B
    J Inherit Metab Dis; 2011 Aug; 34(4):929-39. PubMed ID: 21541725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse model of a human congenital disorder of glycosylation caused by loss of PMM2.
    Chan B; Clasquin M; Smolen GA; Histen G; Powe J; Chen Y; Lin Z; Lu C; Liu Y; Cang Y; Yan Z; Xia Y; Thompson R; Singleton C; Dorsch M; Silverman L; Su SM; Freeze HH; Jin S
    Hum Mol Genet; 2016 Jun; 25(11):2182-2193. PubMed ID: 27053713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.